Sector Chart Sensorion

Stocks

ALSEN

FR0012596468

Biotechnology & Medical Research

Real-time Euronext Paris 13:16:06 13/08/2026 +04			5-day change	1st Jan Change
0.2955 ^EUR	+4.23%		+3.87%	-12.31%

06-11	Sensorion continues its decline despite Stifel's positive outlook
06-10	Sensorion Achieves Key Regulatory Milestones for Sens-601 for Gjb2-Related Hearing Loss and Selects Program as Lead Gene Therapy Candidate	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes